miércoles, 30 de septiembre de 2020

For two decades, the FDA approval process for opioids had numerous shortcomings, study finds - STAT

For two decades, the FDA approval process for opioids had numerous shortcomings, study finds - STAT

Daily Recap



STAT Plus: For two decades, the FDA approval process for opioids had numerous shortcomings, study finds

By ED SILVERMAN


“Our study shows that there are evidence gaps that the FDA needs to address in approving new opioids,” said study co-author Thomas Moore.

No hay comentarios:

Publicar un comentario